|
|
|
|
|
|
|
Array BioPharma Inc. (ARRY)
|
|
19 1.5 (8.57%)
|
06-19 16:00
|
|
Open:
|
17.3
|
Pre. Close:
|
17.5
|
|
High:
|
19.02
|
Low:
|
17.15
|
|
Volume:
|
3,857,241
|
Market Cap:
|
4002M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
19.047 - 19.154
|
19.154 - 19.251
|
|
Low:
|
16.889 - 17.018
|
17.018 - 17.137
|
|
Close:
|
18.795 - 19
|
19 - 19.188
|
|
|
|
Technical analysis (as of: 2018-06-19 4:21:49 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 22.22 One year: 25.95
|
|
Support:
|
Support1: 16.64 Support2: 15.17
|
|
Resistance:
|
Resistance1:
19.02 Resistance2: 22.22
|
|
Pivot:
|
17.55
|
|
Moving Averages:
|
MA(5): 18.04 MA(20): 17.11
MA(100): 16.13 MA(250): 12.84
|
|
MACD:
|
MACD(12,26):
0.79 Signal(12,26,9): 0.72
|
|
%K %D:
|
%K(14,3): 78.62 %D(3): 74.90 
|
|
RSI:
|
RSI(14): 69.14
|
|
52-Week:
|
High: 19.02
Low: 7.15 Change(%): 111.3
|
|
Average Vol(K):
|
3-Month: 252086
10-Days 281144
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.ARRY has closed below upper band by 2.7%. Bollinger Bands are 8.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-06-18T08:00:00-04:00
Array BioPharma to Present Overall Survival Results from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the ESMO 20th World Congress on Gastrointestinal Cancer
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
